Clinical

Dataset Information

A Study of Cologuard in an Average Risk Population Assessing a Three Year Test Interval


ABSTRACT: This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Screening

PROVIDER: 2188144 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR